Pricing Log in Create free account

Alumis Inc. (ALMS) vs Obsidian Therapeutics, Inc (OBX)

Alumis Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Alumis Inc. and Obsidian Therapeutics, Inc are of similar size ($854.4M and $848.8M). Across the 4 metrics below, Alumis Inc. leads on 3 and Obsidian Therapeutics, Inc on 1.

Valuation

Metric ALMS OBX Biotechnology median
P/E n/m — 10.96
P/S 110.64 n/m 9.52
P/B 1.81 n/m 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 42.74 n/m 9.00
Earnings yield (59.17%) — (32.09%)
Free cash flow yield (42.98%) 0.00% (22.62%)

Profitability

Metric ALMS OBX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (6,204.39%) — 0.00%
Net margin (5,933.45%) — 0.00%
Free cash flow margin (4,755.33%) — 0.00%
Return on equity (93.65%) — (50.12%)
Return on assets (74.94%) — (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALMS OBX Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 72.45% (11.60%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ALMS OBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.74 4.21 4.74
Net debt to EBITDA 0.69 0.77 1.01

Dividend

Metric ALMS OBX Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ALMS OBX Biotechnology median
Market cap 854.37m 848.76m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack